PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 12, 2020EP Europace

Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Previous studies failed to show benefit from adding linear ablation or CFAE to PVI for persistent AF recurrence, prompting evaluation of whether PVI alone is non-inferior.

Does pulmonary vein isolation alone prevent recurrence of atrial arrhythmias non-inferiorly to PVI plus extensive ablation in patients with persistent atrial fibrillation?

Population

512 patients with persistent AF undergoing initial catheter ablation

Comparison

PVI alone vs PVI plus CFAE and/or linear ablation

Design

Randomized non-inferiority trial

Follow-up

12 months

Key result

PVI alone was not noninferior to PVI plus linear or CFAE ablation for preventing recurrence of atrial arrhythmias at 12 months (HR 1.56; 95% CI 1.10-2.24; P=0.3062 for noninferiority).

Authors

KIKoichi InoueSHShungo HikosoMMMasaharu Masuda

Discussion

Loading...

Member takes

Overview

PVI alone may suffice initially in persistent AF; leaves open whether adjunctive ablation improves outcomes in randomized trials.

Study Design

Type

RCT (n=512)

Randomization

1:1 ratio

Structured PICO

Does pulmonary vein isolation alone prevent recurrence of atrial arrhythmias non-inferiorly to PVI plus extensive ablation in patients with persistent atrial fibrillation?

P
Population
512 patients with persistent atrial fibrillation undergoing an initial catheter ablation, followed for 12 months.
I
Intervention
Pulmonary vein isolation (PVI) alone
C
Comparator
PVI plus complex fractionated atrial electrogram (CFAE) and/or linear ablation
O
Outcome
Recurrence of atrial fibrillation, atrial flutter, and/or atrial tachycardia at 12 monthscomposite

Main Result

Hazard Ratio: 1.56 (95% CI 1.1–2.24)

Absolute Event Rate: 71.3% vs 78.3%

p-value: p=0.3062 for noninferiority

In patients with persistent atrial fibrillation, PVI alone failed to demonstrate non-inferiority to PVI plus linear or CFAE ablation for preventing arrhythmia recurrence at 12 months, suggesting the more extensive strategy may improve clinical efficacy.

Cite This Study

Inoue et al. (2020) conducted an RCT in Persistent atrial fibrillation (n=512). Pulmonary vein isolation (PVI) alone vs. PVI plus complex fractionated atrial electrogram (CFAE) and/or linear ablation was evaluated on Recurrence of AF, atrial flutter, and/or atrial tachycardia (HR 1.56, 95% CI 1.10-2.24, p=0.3062 for noninferiority). PVI alone was not noninferior to PVI plus linear or CFAE ablation for preventing recurrence of atrial arrhythmias at 12 months (HR 1.56; 95% CI 1.10-2.24; P=0.3062 for noninferiority).

synapsesocial.com/papers/6a86c68f7fdf9298f89eb30chttps://doi.org/10.1093/europace/euaa293
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long‐Term Impact of Additional Ablation After Pulmonary Vein Isolation: Results From EARNEST‐PVI Trial2023 · 28 citations
  2. 2Pulmonary Vein Isolation With Optimized Linear Ablation vs Pulmonary Vein Isolation Alone for Persistent AF2024 · 108 citations
  3. 3Anatomy versus physiology-guided ablation for persistent atrial fibrillation2020 · 2 citations
  4. 4Ablation of persistent atrial fibrillation based on high density voltage mapping and complex fractionated atrial electrograms2021 · 21 citations
  5. 5Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials2010 · 63 citations